- Stocks
- Pharma & Healthcare
- Soni Medicare
Soni Medicare share price
NSE: SMLPharma & HealthcareOther Industrial Metals & Mining
Soni Medicare at a glance
With a market capitalisation of ₹30 Cr, it ranks 3380th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Other Industrial Metals & Mining.
Its return on equity was 19.4% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹6 Cr (−15.1% year on year) and net profit −₹0 Cr (−202.8%), on a standalone basis. Promoters held 69.79% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹30 CrRank 3380 on NSE
- Price to book
- 3.58×FY25
- EPS (TTM)
- −₹5.94to Q4 FY26
- ROE
- 19.4%FY25
- ROCE
- 31.1%FY25
- Debt to equity
- 0.08FY25
- Net profit margin
- 9.9%FY25
- Book value / share
- ₹95.14FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Soni Medicare quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr |
| Revenue YoY | −6.1% | +11.9% | +39.8% | +0.1% | +2.8% | −25.5% | −28.7% | −15.1% |
| Net profit | −₹1 Cr | ₹0 Cr | −₹0 Cr | ₹0 Cr | −₹0 Cr | −₹1 Cr | −₹1 Cr | −₹0 Cr |
| Net profit YoY | −1,066.7% | +1,466.7% | — | — | — | −295.7% | — | −202.8% |
| Net margin | −12.3% | 5.6% | −1.7% | 5.2% | −4.0% | −14.8% | −21.1% | −6.3% |
| EPS | −₹2.03 | ₹1.09 | −₹0.31 | ₹0.55 | −₹0.68 | −₹2.16 | −₹2.65 | −₹0.45 |
Soni Medicare financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹6 Cr | ₹38 Cr | ₹67 Cr | ₹109 Cr | ₹115 Cr | ₹157 Cr |
| Operating profit | ₹6 Cr | ₹9 Cr | ₹13 Cr | ₹14 Cr | ₹16 Cr | ₹24 Cr |
| Net profit | ₹6 Cr | ₹8 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr | ₹16 Cr |
| EPS (₹) | −₹244.80 | ₹330.96 | ₹457.43 | ₹446.77 | ₹484.01 | ₹21.80 |
| Cash from operations | ₹1 Cr | −₹1 Cr | −₹11 Cr | −₹2 Cr | ₹4 Cr | −₹17 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
| Shareholders' equity | ₹6 Cr | ₹14 Cr | ₹25 Cr | ₹36 Cr | ₹47 Cr | ₹80 Cr |
Soni Medicare shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 69.79% | 69.79% | 69.79% | 69.79% | 69.79% | 69.79% |
| Non-institutions | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% |
Soni Medicare vs peers
The listed Pharma & Healthcare companies nearest to Soni Medicare by market capitalisation.
Ask anything about Soni Medicare
Pivot answers on the live chart with evidence you can check, and tests strategies against SML's own history. Try: “Why has SML moved over the last three months?” · “Backtest a 50-day moving-average crossover on SML over five years” · “Compare SML with MEDICAPQ on margins and valuation”
Frequently asked questions about Soni Medicare
What is the market cap of Soni Medicare?
Soni Medicare's market capitalisation is ₹30 Cr (₹30 Cr) at the 22 Oct 2026 close, ranking 3380th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Soni Medicare?
Return on equity was 19.4% in FY25 and return on capital employed was 31.1% in FY25 (standalone figures).
Is Soni Medicare a debt-free company?
No. Soni Medicare's debt-to-equity ratio was 0.08 in FY25, with total debt of ₹0 Cr.
What were Soni Medicare's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Soni Medicare reported revenue of ₹6 Cr, −15.1% year on year, and net profit of −₹0 Cr, −202.8% year on year.
What is the shareholding pattern of Soni Medicare?
As of 30 Jun 2026: promoters 69.79%, non-institutions 30.21%.
Who are Soni Medicare's competitors?
The listed Pharma & Healthcare companies closest to Soni Medicare by market cap are Medi-Caps, KK Shah Hospita, Panjon, Chennai Meenaks, Tejnaksh and SAMSRITA LABS.
Is Soni Medicare a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Soni Medicare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SML against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text